Correlation Between Rani Therapeutics and Homology Medicines
Can any of the company-specific risk be diversified away by investing in both Rani Therapeutics and Homology Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rani Therapeutics and Homology Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rani Therapeutics Holdings and Homology Medicines, you can compare the effects of market volatilities on Rani Therapeutics and Homology Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rani Therapeutics with a short position of Homology Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rani Therapeutics and Homology Medicines.
Diversification Opportunities for Rani Therapeutics and Homology Medicines
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Rani and Homology is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Rani Therapeutics Holdings and Homology Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Homology Medicines and Rani Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rani Therapeutics Holdings are associated (or correlated) with Homology Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Homology Medicines has no effect on the direction of Rani Therapeutics i.e., Rani Therapeutics and Homology Medicines go up and down completely randomly.
Pair Corralation between Rani Therapeutics and Homology Medicines
Given the investment horizon of 90 days Rani Therapeutics Holdings is expected to under-perform the Homology Medicines. In addition to that, Rani Therapeutics is 1.43 times more volatile than Homology Medicines. It trades about -0.01 of its total potential returns per unit of risk. Homology Medicines is currently generating about 0.02 per unit of volatility. If you would invest 110.00 in Homology Medicines on August 31, 2024 and sell it today you would lose (1.00) from holding Homology Medicines or give up 0.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.56% |
| Values | Daily Returns |
Rani Therapeutics Holdings vs. Homology Medicines
Performance |
| Timeline |
| Rani Therapeutics |
| Homology Medicines |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Rani Therapeutics and Homology Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rani Therapeutics and Homology Medicines
The main advantage of trading using opposite Rani Therapeutics and Homology Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rani Therapeutics position performs unexpectedly, Homology Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Homology Medicines will offset losses from the drop in Homology Medicines' long position.| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
| Homology Medicines vs. Passage Bio | Homology Medicines vs. Stoke Therapeutics | Homology Medicines vs. Adaptimmune Therapeutics Plc | Homology Medicines vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |